Uveitis Treatment Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Uveitis Treatment Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Uveitis Treatment Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global uveitis treatment
  market size reached US 1.7 Billion in 2023.
• Uveitis refers to a condition that causes
  inflammation of the middle layer of tissue in the
  eyewall uvea. It causes swelling that can damage
  the eye tissues, leading to poor vision or
  blindness. Uveitis is mainly caused by autoimmune
  diseases in which the body attacks itself,
  causing inflammation, infection and tumor in the
  eyes or other parts of the body.
• The treatment for uveitis involves a therapeutic
  process that can heal the inflammation of the
  uvea and surrounding tissues. It is treated with
  the help of drugs such as cycloplegic agents,
  anti-inflammatory, antimicrobials, as well as
  immunotherapy and targeted therapies. Uveitis
  treatment also provides the patient with relief
  from the pain, prevents further damage of the
  tissues, and restores vision loss.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/uveitis-treatment-marke
  t/requestsample

4
Report Description

• Global Uveitis Treatment Market Trends
• The market is driven by the increasing prevalence
  of uveitis and other infectious eye disorders in
  individuals. Besides this, the growing awareness
  regarding the need for proper treatment among
  patients is also encouraging the adoption of
  advanced therapeutics. In addition to this, the
  rising complication associated with uveitis has
  resulted in increased investment in healthcare,
  thereby fueling the market growth. Furthermore,
  individuals with diabetes, eye injuries,
  cataracts, glaucoma, band keratopathy, and
  inflammatory disorders are more susceptible to
  uveitis. As a result, governments of different
  nations are taking initiatives to accelerate the
  approval of drugs in the pipeline and new routes
  of drug administration to improve the efficacy of
  the drugs. In addition to this, there has been a
  rise in the number of clinical trials for eye
  inflammation treatments for refractory posterior
  and intermediate uveitis across the globe.
  Nowadays, several leading manufacturers have
  increased their production capacity of the
  medication. Moreover, extensive research and
  development (RD) activities in the field of
  ophthalmology have led to the introduction of
  advanced uveitis treatment, creating lucrative
  opportunities in the market.
• Looking forward, the market is expected to grow
  at a CAGR of 4.6 during the forecast period
  (2024-2032).
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/uveitis-treatment-marke
  t

5
Report Segmentation

• Breakup by Treatment Type
• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Antibiotics
• Antivirals
• Antifungal
• Analgesics
• Breakup by Disease Type
• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Panuveitis

6
Report Segmentation

• Breakup by Cause
• Infectious
• Non-infectious
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• AbbVie Inc.
• Alimera Sciences Inc.
• Bausch Lomb Incorporated (Bausch Health)
• Enzo Biochem Inc.
• Eyegate Pharmaceuticals Inc.
• Eyepoint Pharmaceuticals Inc.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Uveitis Treatment
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Treatment Type    6.1  
   Corticosteroids        6.1.1 Market
  Trends        6.1.2 Market Forecast    6.2
     Immunosuppressant        6.2.1 Market
  Trends        6.2.2 Market Forecast    6.3
     Monoclonal Antibodies        6.3.1 Market
  Trends        6.3.2 Market Forecast       

11
Table of Contents

•     6.4    Cycloplegic Agents        6.4.1
  Market Trends        6.4.2 Market
  Forecast    6.5    Antibiotics        6.5.1
  Market Trends        6.5.2 Market
  Forecast    6.6    Antivirals        6.6.1
  Market Trends        6.6.2 Market
  Forecast    6.7    Antifungal        6.7.1
  Market Trends        6.7.2 Market
  Forecast    6.8    Analgesics        6.8.1
  Market Trends        6.8.2 Market Forecast7
    Market Breakup by Disease Type    7.1  
   Anterior Uveitis        7.1.1 Market
  Trends        7.1.2 Market Forecast    7.2
     Posterior Uveitis        7.2.1 Market
  Trends        7.2.2 Market Forecast    7.3
     Intermediate Uveitis        7.3.1 Market
  Trends        7.3.2 Market Forecast    7.4
     Panuveitis        7.4.1 Market
  Trends        7.4.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/uveitis-treatment-market/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com